+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Postpartum Hemorrhage Devices Market Size, Share & Industry Trends Analysis Report By Product, By Regional Outlook and Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 118 Pages
  • May 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5615571
The Global Postpartum Hemorrhage (PPH) Devices Market size is expected to reach $1.05 billion by 2028, rising at a market growth of 5.2% CAGR during the forecast period.



Postpartum hemorrhage (PPH) is the most prevalent type of obstetric hemorrhage and one of the primary causes of maternal mortality. Blood loss from vaginal or cesarean delivery is known as PPH. Postpartum hemorrhage is classified based on the amount of blood lost. Blood loss of less than 500 mL is considered primary PPH, while blood loss of more than 500 mL is considered secondary PPH. Modern PPH treatment devices outperform previous procedures since they are designed to treat uterine diseases and difficulties with uterine contractions. PPH devices are non-pneumatic anti-shock garments, uterine balloon tamponade, and inject prefilled injectable systems that are used as second-line intervention devices. These devices are helpful in stopping blood flow and stabilizing the patient's condition until more serious medical help arrives.

Uterine atony, a disease in which the uterus fails to contract following the birth of the baby, is the most prevalent cause of PPH. First response interventions, such as uterotonic drugs (primarily oxytocin), isotonic crystalloids, tranexamic acid, and uterine massage; and, if necessary, refractory PPH interventions, such as compressive measures (aortic compression or bimanual uterine compression), intrauterine balloon tamponade, and nonpneumatic anti shock garment (NASG). Surgical intervention (compressive sutures, artery ligation, or hysterectomy) is required if these methods fail. In 2012, the World Health Organization (WHO) issued a conditional recommendation in favor of uterine balloon tamponade (UBT) in cases when uterotonics were unavailable or ineffective in reducing bleeding.

COVID-19 Impact Analysis


The COVID-19 pandemic wrought havoc on people's health and the economy around the world. It has had an impact on entire economies and businesses, as well as individual careers and lives. The outbreak also led to the unfortunate demise of millions across the world. As enterprises turn their focus away from development prospects and onto implementing exceptional measures to avoid the harmful impact of the COVID-19 pandemic, the stress of maintaining revenue levels at pre-COVID levels has become the new normal.

The postpartum hemorrhage devices market is expected to rise in response to the COVID-19 outbreak. Covid-19 infection raises the risk of pregnancy complications such as postpartum hemorrhage, which helps the market grow by increasing the number of PPH patients.

Market Growth Factors:


Rise in Complications Like Obstetric Hemorrhage


The postpartum hemorrhage devices market is growing due to a rise in complications such as acute postpartum hemorrhage. The most common and dangerous complication of childbirth is obstetric hemorrhage. Postpartum hemorrhage (PPH) is traditionally described as a blood loss of more than 500 mL estimated with a vaginal delivery or more than 1000 mL estimated during a cesarean delivery. The American College of Obstetrics and Gynecology characterized this in 2017 as an accumulation of blood loss of more than 1000 mL with signs and symptoms of hypovolemia within 24 hours after the birth procedure, regardless of delivery mode.

Growing Investment in Healthcare Sector in Developed and Developing Countries


Governments of developing countries such as India and China are investing heavily in the healthcare sector of their respective countries. In 2020, for instance, the Indian health tech business was estimated to be worth $1.9 billion. It is predicted to reach $ 5 billion by 2023, with a CGAR of 39%. The Indian digital healthcare market was worth USD 1.50 billion in 2018 and is expected to grow to USD 6.26 billion by 2024. The expansion of the healthcare business is likely to positively impact the postpartum hemorrhage devices market. Even in developed countries, such as the United States, governments are spending enormous amounts to modernize and expand the healthcare sector.

Marketing Restraining Factor:


Inaccuracies in Measuring Blood Loss in Obstetric Hemorrhage


Postpartum hemorrhage is the leading cause of maternal death in the United States, accounting for about 11% of all maternal deaths. Significantly, obstetric hemorrhage is responsible for 54-93% of maternal deaths. Health care providers’ inaccurate estimation of actual blood loss at the time of birth and in the immediate postpartum period is a major cause of delayed hemorrhage response, according to studies. Underestimations of blood loss lead healthcare providers into believing that deployment of postpartum hemorrhage are not necessary, thus, limiting the use of postpartum hemorrhage devices.

Product Outlook


Based on Product, the market is segmented into Uterine Tamponade Devices, Prefilled Injection System, and Non-Pneumatic Anti-Shock Garment. The uterine tamponade devices segment acquired the largest revenue share in the postpartum hemorrhage devices market in 2021. This is due to the device's ability to work quickly and reduce the need for risky and expensive surgical procedures. Furthermore, the device is quick responding and less intrusive, making it a safe way to manage PPH. Moreover, since the gadget kit contains few pieces, it can be installed quickly and easily, increasing its efficacy.

Regional Outlook


Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The Asia Pacific acquired the highest revenue share in the postpartum hemorrhage devices market in 2021. Government initiatives to reduce maternal deaths and enable access to preferred therapy for effective management throughout the third phase of labor are projected to benefit the Asia-Pacific market even more and raise the demand for PPH devices in the upcoming years. Furthermore, the region's dearth of skilled caretakers, operating skills, and blood-transfusion facilities are expected to fuel the demand for PPH treatment devices.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teleflex, Inc., Becton, Dickinson and Company, Bactiguard Holding AB, Utah Medical Products, Inc., Organon & Co., Cook Medical, Inc., PATH, Obstetrx, Inc., Zoex Corporation, and 3rd Stone Design, Inc.

Scope of the Study


Market Segments Covered in the Report:


By Product

  • Uterine Tamponade Devices
  • Prefilled Injection System
  • Non-Pneumatic Anti-Shock Garment

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players


List of Companies Profiled in the Report:

  • Teleflex, Inc.
  • Becton, Dickinson and Company
  • Bactiguard Holding AB
  • Utah Medical Products, Inc.
  • Organon & Co.
  • Cook Medical, Inc.
  • PATH
  • Obstetrx, Inc.
  • Zoex Corporation
  • 3rd Stone Design, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Postpartum Hemorrhage (PPH) Devices Market, by Product
1.4.2 Global Postpartum Hemorrhage (PPH) Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Postpartum Hemorrhage (PPH) Devices Market by Product
3.1 Global Uterine Tamponade Devices Market by Region
3.2 Global Prefilled Injection System Market by Region
3.3 Global Non-Pneumatic Anti-Shock Garment Market by Region
Chapter 4. Global Postpartum Hemorrhage (PPH) Devices Market by Region
4.1 North America Postpartum Hemorrhage (PPH) Devices Market
4.1.1 North America Postpartum Hemorrhage (PPH) Devices Market by Product
4.1.1.1 North America Uterine Tamponade Devices Market by Country
4.1.1.2 North America Prefilled Injection System Market by Country
4.1.1.3 North America Non-Pneumatic Anti-Shock Garment Market by Country
4.1.2 North America Postpartum Hemorrhage (PPH) Devices Market by Country
4.1.2.1 US Postpartum Hemorrhage (PPH) Devices Market
4.1.2.1.1 US Postpartum Hemorrhage (PPH) Devices Market by Product
4.1.2.2 Canada Postpartum Hemorrhage (PPH) Devices Market
4.1.2.2.1 Canada Postpartum Hemorrhage (PPH) Devices Market by Product
4.1.2.3 Mexico Postpartum Hemorrhage (PPH) Devices Market
4.1.2.3.1 Mexico Postpartum Hemorrhage (PPH) Devices Market by Product
4.1.2.4 Rest of North America Postpartum Hemorrhage (PPH) Devices Market
4.1.2.4.1 Rest of North America Postpartum Hemorrhage (PPH) Devices Market by Product
4.2 Europe Postpartum Hemorrhage (PPH) Devices Market
4.2.1 Europe Postpartum Hemorrhage (PPH) Devices Market by Product
4.2.1.1 Europe Uterine Tamponade Devices Market by Country
4.2.1.2 Europe Prefilled Injection System Market by Country
4.2.1.3 Europe Non-Pneumatic Anti-Shock Garment Market by Country
4.2.2 Europe Postpartum Hemorrhage (PPH) Devices Market by Country
4.2.2.1 Germany Postpartum Hemorrhage (PPH) Devices Market
4.2.2.1.1 Germany Postpartum Hemorrhage (PPH) Devices Market by Product
4.2.2.2 UK Postpartum Hemorrhage (PPH) Devices Market
4.2.2.2.1 UK Postpartum Hemorrhage (PPH) Devices Market by Product
4.2.2.3 France Postpartum Hemorrhage (PPH) Devices Market
4.2.2.3.1 France Postpartum Hemorrhage (PPH) Devices Market by Product
4.2.2.4 Russia Postpartum Hemorrhage (PPH) Devices Market
4.2.2.4.1 Russia Postpartum Hemorrhage (PPH) Devices Market by Product
4.2.2.5 Spain Postpartum Hemorrhage (PPH) Devices Market
4.2.2.5.1 Spain Postpartum Hemorrhage (PPH) Devices Market by Product
4.2.2.6 Italy Postpartum Hemorrhage (PPH) Devices Market
4.2.2.6.1 Italy Postpartum Hemorrhage (PPH) Devices Market by Product
4.2.2.7 Rest of Europe Postpartum Hemorrhage (PPH) Devices Market
4.2.2.7.1 Rest of Europe Postpartum Hemorrhage (PPH) Devices Market by Product
4.3 Asia Pacific Postpartum Hemorrhage (PPH) Devices Market
4.3.1 Asia Pacific Postpartum Hemorrhage (PPH) Devices Market by Product
4.3.1.1 Asia Pacific Uterine Tamponade Devices Market by Country
4.3.1.2 Asia Pacific Prefilled Injection System Market by Country
4.3.1.3 Asia Pacific Non-Pneumatic Anti-Shock Garment Market by Country
4.3.2 Asia Pacific Postpartum Hemorrhage (PPH) Devices Market by Country
4.3.2.1 China Postpartum Hemorrhage (PPH) Devices Market
4.3.2.1.1 China Postpartum Hemorrhage (PPH) Devices Market by Product
4.3.2.2 Japan Postpartum Hemorrhage (PPH) Devices Market
4.3.2.2.1 Japan Postpartum Hemorrhage (PPH) Devices Market by Product
4.3.2.3 India Postpartum Hemorrhage (PPH) Devices Market
4.3.2.3.1 India Postpartum Hemorrhage (PPH) Devices Market by Product
4.3.2.4 South Korea Postpartum Hemorrhage (PPH) Devices Market
4.3.2.4.1 South Korea Postpartum Hemorrhage (PPH) Devices Market by Product
4.3.2.5 Singapore Postpartum Hemorrhage (PPH) Devices Market
4.3.2.5.1 Singapore Postpartum Hemorrhage (PPH) Devices Market by Product
4.3.2.6 Malaysia Postpartum Hemorrhage (PPH) Devices Market
4.3.2.6.1 Malaysia Postpartum Hemorrhage (PPH) Devices Market by Product
4.3.2.7 Rest of Asia Pacific Postpartum Hemorrhage (PPH) Devices Market
4.3.2.7.1 Rest of Asia Pacific Postpartum Hemorrhage (PPH) Devices Market by Product
4.4 LAMEA Postpartum Hemorrhage (PPH) Devices Market
4.4.1 LAMEA Postpartum Hemorrhage (PPH) Devices Market by Product
4.4.1.1 LAMEA Uterine Tamponade Devices Market by Country
4.4.1.2 LAMEA Prefilled Injection System Market by Country
4.4.1.3 LAMEA Non-Pneumatic Anti-Shock Garment Market by Country
4.4.2 LAMEA Postpartum Hemorrhage (PPH) Devices Market by Country
4.4.2.1 Brazil Postpartum Hemorrhage (PPH) Devices Market
4.4.2.1.1 Brazil Postpartum Hemorrhage (PPH) Devices Market by Product
4.4.2.2 Argentina Postpartum Hemorrhage (PPH) Devices Market
4.4.2.2.1 Argentina Postpartum Hemorrhage (PPH) Devices Market by Product
4.4.2.3 UAE Postpartum Hemorrhage (PPH) Devices Market
4.4.2.3.1 UAE Postpartum Hemorrhage (PPH) Devices Market by Product
4.4.2.4 Saudi Arabia Postpartum Hemorrhage (PPH) Devices Market
4.4.2.4.1 Saudi Arabia Postpartum Hemorrhage (PPH) Devices Market by Product
4.4.2.5 South Africa Postpartum Hemorrhage (PPH) Devices Market
4.4.2.5.1 South Africa Postpartum Hemorrhage (PPH) Devices Market by Product
4.4.2.6 Nigeria Postpartum Hemorrhage (PPH) Devices Market
4.4.2.6.1 Nigeria Postpartum Hemorrhage (PPH) Devices Market by Product
4.4.2.7 Rest of LAMEA Postpartum Hemorrhage (PPH) Devices Market
4.4.2.7.1 Rest of LAMEA Postpartum Hemorrhage (PPH) Devices Market by Product
Chapter 5. Company Profiles
5.1 Teleflex, Inc.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Segmental and Regional Analysis
5.1.4 Research & Development Expense
5.2 Becton, Dickinson and Company
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expense
5.3 Bactiguard Holding AB
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Regional Analysis
5.4 Utah Medical Products, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Regional Analysis
5.4.4 Research & Development Expense
5.5 Organon & Co.
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Regional Analysis
5.5.4 Research & Development Expenses
5.5.5 Recent strategies and developments:
5.5.5.1 Approvals and Trials:
5.5.5.2 Acquisition and Mergers:
5.6 Cook Medical, Inc. (Cook Group)
5.6.1 Company Overview
5.7 PATH
5.7.1 Company Overview
5.7.2 Financial Analysis
5.7.3 Recent strategies and developments:
5.7.3.1 Product Launches and Product Expansions:
5.8 Obstetrx, Inc.
5.8.1 Company Overview
5.9 Zoex Corporation
5.9.1 Company Overview
5.10. 3rd Stone Design, Inc.
5.10.1 Company Overview

Companies Mentioned

  • Teleflex, Inc.
  • Becton, Dickinson and Company
  • Bactiguard Holding AB
  • Utah Medical Products, Inc.
  • Organon & Co.
  • Cook Medical, Inc.
  • PATH
  • Obstetrx, Inc.
  • Zoex Corporation
  • 3rd Stone Design, Inc.

Methodology

Loading
LOADING...

Table Information